Johnson & Johnson’s global sales of contact lenses fell by 7.1 percent year-on-year in the third quarter to $830 million. At constant currency rates, revenues fell by 7.2 percent as sales of contact lenses continued to be negatively impacted the Covid-19 pandemic. But, sales in the U.S. grew partially driven by a higher level of stocking. The trend in the third quarter also marked a sharp improvement from the 34.1 percent drop, on a reported basis, posted in the second quarter.

In the U.S. contact lens revenues rose by 10.9 percent to $375 million, while international sales declined by 18.1 percent to $455 million, with sales in local currencies down by 18.2 percent.

As regards J&J’s vision care division, sales were down by 9.4 percent to $1,081 million in the third quarter, or by 9.5 percent at constant currency rates.